Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17376011 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL80815 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL6570483 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL613567 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL15103122 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL150831 | 0.97 | USP2 (0.36) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL3592238 | 0.93 | — | — | |
| SCHEMBL16424464 | 0.86 | — | — | |
| SCHEMBL13404962 | 0.86 | — | — | |
| SCHEMBL1129493 | 0.85 | USP2 (0.33) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240117279-A1 | BIODEGRADABLE SOIL RELEASE POLYESTER POLYMER AND THE CLEANING COMPOSITION COMPRISING THE SAME | SPECIALTY OPERATIONS FRANCE (FR) | 2024-04-11 | — | — | US | claimed |
| EP-4288514-A1 | BIODEGRADABLE SOIL RELEASE POLYESTER POLYMER AND THE CLEANING COMPOSITION COMPRISING THE SAME | SPECIALTY OPERATIONS FRANCE (FR) | 2023-12-13 | — | — | EP | claimed |
| WO-2022167655-A1 | BIODEGRADABLE SOIL RELEASE POLYESTER POLYMER AND THE CLEANING COMPOSITION COMPRISING THE SAME | RHODIA OPERATIONS (FR) | 2022-08-11 | — | — | WO | claimed |
| US-12630677-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | ALECTOS THERAPEUTICS 1NC (CA) | 2026-04-28 | — | — | US | disclosed |
| EP-3966199-B1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC (CA) | 2026-03-18 | — | — | EP | disclosed |
| WO-2025069725-A1 | POLISHING COMPOSITION, CONCENTRATED SOLUTION OF POLISHING COMPOSITION, AND POLISHING METHOD | 株式会社フジミインコーポレーテッド | 2025-04-03 | — | — | WO | disclosed |
| CN-114174263-B | Non-lysosomal glucosylceramidase inhibitors and uses thereof | 阿勒克图治疗公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20240301114-A1 | POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-12 | — | — | US | disclosed |
| US-20240294712-A1 | RESIN SUITABLE FOR THREE-DIMENSIONAL PRINTING | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-09-05 | — | — | US | disclosed |
| US-12006401-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| EP-0403543-B1 | POLYFUNCTIONAL VINYL ETHER TERMINATED ESTER OLIGOMERS | AlliedSignal Inc. (US) | 1993-08-04 | — | — | EP | disclosed |
| EP-0393149-B1 | VINYL ETHER TERMINATED ESTER AND URETHANE RESINS FROM BIS(HYDROXYALKYL)CYCLOALKANES | AlliedSignal Inc. (US) | 1992-12-09 | — | — | EP | disclosed |
| EP-0403543-A1 | POLYFUNCTIONAL VINYL ETHER TERMINATED ESTER OLIGOMERS. | ALLIED SIGNAL INC (US) | 1990-12-27 | — | — | EP | disclosed |
| EP-0393149-A1 | VINYL ETHER TERMINATED ESTER AND URETHANE RESINS FROM BIS(HYDROXYALKYL)CYCLOALKANES. | ALLIED SIGNAL INC (US) | 1990-10-24 | — | — | EP | disclosed |
| EP-0366479-A2 | Process for preparation of polyester | MITSUBISHI RAYON CO., LTD. (JP) | 1990-05-02 | — | — | EP | disclosed |
| WO-1989008097-A1 | POLYFUNCTIONAL VINYL ETHER TERMINATED ESTER OLIGOMERS | ALLIED-SIGNAL INC. (US) | 1989-09-08 | — | — | WO | disclosed |
| WO-1989006228-A1 | VINYL ETHER TERMINATED ESTER AND URETHANE RESINS FROM BIS(HYDROXYALKYL)CYCLOALKANES | ALLIED-SIGNAL INC. (US) | 1989-07-13 | — | — | WO | disclosed |
| US-4845265-A | RAPID CURING; SOLVENT RESISTANT COATINGS | ALLIED-SIGNAL INC. (US) | 1989-07-04 | — | — | US | disclosed |
| US-4775732-A | HIGH SPEED CURING | ALLIED-SIGNAL INC. (US) | 1988-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240301114-A1 | POLYCARBONATE DIOL AND PRODUCING METHOD THEREOF, AND POLYURETHANE AND ACTIVE ENERGY RAY-CURABLE POLYMER COMPOSITION BOTH FORMED USING SAME | DIMT1, CAD, PUF60 | USP2 543/4885ALDH1A1 1739/4885LMNA 1615/4885 |
| US-12630677-B2 | Resin suitable for three-dimensional printing | HTR3D, CAD, SMCHD1 | USP2 465/4885ALDH1A1 843/4885LMNA 2651/4885 |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | GBA1, GBA2, MAN2B1 | USP2 1536/4885ALDH1A1 1393/4885LMNA 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.